BRIEF-Sino Biopharmaceutical Posts Qtrly Underlying Profit Attributable RMB976.38 Mln

May 21 (Reuters) - Sino Biopharmaceutical Ltd:

* QTRLY REVENUE RMB6,208.03 MILLION, AN INCREASE OF ABOUT 33.4%

* QTRLY UNDERLYING PROFIT ATTRIBUTABLE RMB976.38 MILLION, UP 22.4%

* BOARD HAS DECLARED PAYMENT OF A QUARTERLY DIVIDEND OF HK2 CENTS PER SHARE FOR THREE MONTHS ENDED 31 MARCH, 2019 Source text for Eikon: Further company coverage:

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting